Peregrine Pharmaceuticals shares owned by Sargent Investment Group
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Sargent Investment Group
from 13F filings
Historical chart of Sargent Investment Group investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Sargent Investment Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Sargent Investment Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.4M | 559k | 11.38 |
| 2024-06-30 | $4.3M | 596k | 7.14 |
| 2024-03-31 | $4.6M | 691k | 6.70 |
| 2023-12-31 | $4.6M | 713k | 6.50 |
| 2023-09-30 | $6.8M | 721k | 9.44 |
| 2023-06-30 | $10M | 733k | 13.97 |
| 2023-03-31 | $14M | 746k | 18.75 |
| 2022-12-31 | $11M | 765k | 13.77 |
| 2022-09-30 | $14M | 742k | 18.65 |
| 2022-06-30 | $12M | 754k | 15.26 |
| 2022-03-31 | $15M | 753k | 20.37 |
| 2021-12-31 | $22M | 769k | 29.18 |
| 2021-09-30 | $18M | 812k | 21.57 |
| 2021-06-30 | $22M | 848k | 25.65 |
| 2021-03-31 | $16M | 877k | 18.23 |
| 2020-12-31 | $11M | 927k | 11.54 |
| 2020-09-30 | $8.0M | 1.1M | 7.62 |
| 2020-06-30 | $7.6M | 1.1M | 7.13 |
| 2020-03-31 | $6.0M | 1.2M | 5.11 |
| 2019-12-31 | $6.9M | 894k | 7.67 |
| 2019-09-30 | $3.4M | 637k | 5.30 |
| 2019-06-30 | $3.4M | 613k | 5.60 |
| 2019-03-31 | $2.5M | 600k | 4.25 |
| 2018-12-31 | $2.3M | 555k | 4.10 |